Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
0.308
+0.041 (15.33%)
At close: Nov 22, 2024, 4:00 PM
0.315
+0.007 (2.32%)
After-hours: Nov 22, 2024, 4:04 PM EST
Aptevo Therapeutics Stock Forecast
APVO's stock price has decreased by -96.79% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Aptevo Therapeutics stock has a target of 8.00, which predicts an increase of 2,499.94% from the current stock price of 0.31.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 23, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for APVO is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $15 → $8 | Strong Buy | Maintains | $15 → $8 | +2,499.94% | Sep 23, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $3,036 → $880 | Buy | Maintains | $3,036 → $880 | +285,892.85% | May 13, 2022 |
| Roth Capital | Roth Capital | Strong Buy Maintains $2,816 → $2,200 | Strong Buy | Maintains | $2,816 → $2,200 | +714,882.13% | May 28, 2021 |
| Piper Sandler | Piper Sandler | Buy Maintains $1,408 → $3,036 | Buy | Maintains | $1,408 → $3,036 | +986,575.33% | Nov 11, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $7,392 | Strong Buy | Initiates | $7,392 | +2,402,239.94% | Apr 11, 2018 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-17.58
from -62.62
EPS Next Year
-5.95
from -17.58
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 7.9M | ||
| Avg | n/a | n/a | 3.9M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.12 | -1.23 | -0.65 | ||
| Avg | -17.58 | -5.95 | -3.89 | ||
| Low | -30.87 | -10.29 | -6.86 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.